| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/17/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 02/05/16 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
31 | |
| 01/28/16 | 8-K | Current report filing |
|
5 | |
| 01/20/16 | 8-K | Current report filing |
|
6 | |
| 01/15/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/15/16 | 8-K | Current report filing |
|
6 | |
| 01/13/16 | 8-K | Current report filing |
|
6 | |
| 01/12/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/08/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
48 |
| 01/07/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.